首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Exploration of targeted antitumor therapy

缩写:

ISSN:2692-3114

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引375
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Shishir Singh,Rajeev Nema,Monisha Banerjee et al. Shishir Singh et al.
O6-Methylguanine-DNA methyltransferase (MGMT) acts as a genomic custodian, reversing alkylation damage to preserve DNA integrity. However, when its regulatory balance tips via promoter methylation, polymorphisms, or epigenetic silencing, MG...
Yuting Sheng,Daniel M Han,Mark R Wakefield et al. Yuting Sheng et al.
Cancer is the second leading cause of death globally and in the United States, second only to cardiovascular disease. Unlike many cardiovascular conditions, cancer is often less preventable, manageable, and curable-even with ongoing technol...
Ekaterina S Kuligina,Grigoriy A Yanus,Evgeny N Imyanitov Ekaterina S Kuligina
Liquid biopsy (LB) is a complex of procedures aimed at the detection of tumor-derived fragments (nucleic acids, proteins, cells, etc.) persisting in the blood or other body fluids. It can be utilized for early cancer diagnosis, analysis of ...
Rolla Al-Shalabi,Vuanghao Lim,Ibrahim Al-Deeb et al. Rolla Al-Shalabi et al.
Aim: Angiogenesis, invasion, and tube formation are critical processes in tumor progression and metastasis. The use of nanoparticles derived from natural products presents a promising approach for targeted cancer therapy....
Federica Martorana,Sabrina Nucera,Gianmarco Motta et al. Federica Martorana et al.
Aim: Clinico-pathological features have traditionally guided prognosis and adjuvant therapy for breast cancer (BC) patients. In the past decade, genomic tests such as Oncotype DX entered clinical practice to refine risk s...
Elena V Preobrazhenskaya,Rimma S Mulkidjan,Fyodor A Zagrebin et al. Elena V Preobrazhenskaya et al.
Aim: This study aimed at the identification of new druggable alterations in non-small cell lung carcinomas (NSCLCs). Methods: RNA next ...
Gurkaranjot Singh,Zuhair Chaudhry,Anik Boyadzhyan et al. Gurkaranjot Singh et al.
Colorectal cancer (CRC) is the third leading cause of cancer-related death in the United States. Emerging evidence highlights the significant role of gut microbiota dysbiosis, characterized by a reduction in beneficial bacteria and an incre...
James Gutmans,Hiba Mechahougui James Gutmans
Biliary tract cancers (BTCs) are aggressive malignancies associated with poor prognosis and limited treatment options. Advances in precision oncology, notably the identification of recurrent molecular alterations such as fibroblast growth f...
Anna Sokolenko,Tatiana Gorodnova,Diana Enaldieva et al. Anna Sokolenko et al.
Aim: BRCA1/2-associated breast and ovarian carcinomas are often regarded as a single entity, assuming that BRCA1 and BRCA2 genes are almost equivalent with regard to their clinical significance. However, BRCA1 and BRCA2 g...
Guraustin S Brar,Aidan A Schmidt,Logan R Willams et al. Guraustin S Brar et al.
Osteosarcoma is the most prevalent primary malignant bone tumor affecting adolescents and young adults. Despite advancements in cancer therapies, its prognosis remains poor due to its aggressive nature and early propensity for metastasis-of...